regulation
WHO Cherry-Picked Data on Pesticide, Investigation Finds
WHO Cherry-Picked Data on Pesticide, Investigation Finds
Ashley P. Taylor | Oct 22, 2017
A group evaluating glyphosate’s cancer risk omitted evidence that the chemical is not carcinogenic.
Great Lakes Gray Wolf to Retain Endangered Status
Great Lakes Gray Wolf to Retain Endangered Status
Catherine Offord | Aug 2, 2017
A US Court of Appeals ruled that the Interior Department acted prematurely in removing the animals from the endangered species list.
New FDA Pathway to Accelerate Development of Cell Therapies
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Contributors
Contributors
Diana Kwon | Apr 1, 2017
Meet some of the people featured in the April 2017 issue of The Scientist.
Book Excerpt from <em>The Politics of Cancer</em>
Book Excerpt from The Politics of Cancer
Wendy N. Whitman Cobb | Mar 31, 2017
In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.
House Votes to Limit EPA Decision Making
House Votes to Limit EPA Decision Making
Jef Akst | Mar 31, 2017
The “HONEST” Act, passed by the House this week, would restrict the nature of the research that can inform new regulations at the Environmental Protection Agency. Meanwhile, EPA Administrator Scott Pruitt overrules the agency’s previous recommendation on chlorpyrifos. 
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Q&A: From FDA to Industry
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
Theranos Withdraws Zika Blood Test
Theranos Withdraws Zika Blood Test
Jef Akst | Sep 1, 2016
The embattled company failed to include proper safeguards, according to federal regulators.
Theranos CEO Presents New Device
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.